| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2745 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2350 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 535 | 2021 |
| Attitudes of healthcare workers towards COVID-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020 P Verger, D Scronias, N Dauby, KA Adedzi, C Gobert, M Bergeat, ... Eurosurveillance 26 (3), 2002047, 2021 | 450 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 385 | 2021 |
| Maternal immunisation: collaborating with mother nature A Marchant, M Sadarangani, M Garand, N Dauby, V Verhasselt, L Pereira, ... The lancet infectious diseases 17 (7), e197-e208, 2017 | 201 | 2017 |
| Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections N Dauby, T Goetghebuer, TR Kollmann, J Levy, A Marchant The Lancet Infectious Diseases 12 (4), 330-340, 2012 | 199 | 2012 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 167 | 2022 |
| Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants L Catteau, N Dauby, M Montourcy, E Bottieau, J Hautekiet, ... International journal of antimicrobial agents 56 (4), 106144, 2020 | 138 | 2020 |
| Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial J Declercq, KFA Van Damme, E De Leeuw, B Maes, C Bosteels, ... The Lancet Respiratory Medicine 9 (12), 1427-1438, 2021 | 122 | 2021 |
| Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff C Martin, I Montesinos, N Dauby, C Gilles, H Dahma, ... Journal of Hospital Infection 106 (1), 102-106, 2020 | 113 | 2020 |
| Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis N Dauby, I Muylle, F Mouchet, R Sergysels, MC Payen The Pediatric infectious disease journal 30 (9), 812-813, 2011 | 89 | 2011 |
| The human fetal thymus generates invariant effector γδ T cells P Tieppo, M Papadopoulou, D Gatti, N McGovern, JKY Chan, F Gosselin, ... Journal of Experimental Medicine 217 (3), e20190580, 2019 | 81 | 2019 |
| TCR sequencing reveals the distinct development of fetal and adult human Vγ9Vδ2 T cells M Papadopoulou, P Tieppo, N McGovern, F Gosselin, JKY Chan, ... The Journal of Immunology 203 (6), 1468-1479, 2019 | 76 | 2019 |
| Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis E De Azambuja, M Brandão, H Wildiers, A Laenen, S Aspeslagh, ... ESMO open 5 (5), e000947, 2020 | 75 | 2020 |
| A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer C Nagant, F Ponthieux, J Smet, N Dauby, V Doyen, T Besse-Hammer, ... International Journal of Infectious Diseases 101, 342-345, 2020 | 65 | 2020 |
| Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 D Matuozzo, E Talouarn, A Marchal, P Zhang, J Manry, Y Seeleuthner, ... Genome medicine 15 (1), 22, 2023 | 63 | 2023 |
| Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study N Dauby, S De Wit, M Delforge, VC Necsoi, N Clumeck Journal of the International AIDS Society 14, 1-7, 2011 | 63 | 2011 |
| Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines N Dauby, C Alonso-Vega, E Suarez, A Flores, E Hermann, M Córdova, ... PLoS neglected tropical diseases 3 (12), e571, 2009 | 62 | 2009 |
| Portraying infective endocarditis: results of multinational ID-IRI study H Erdem, E Puca, Y Ruch, L Santos, N Ghanem-Zoubi, X Argemi, ... European Journal of Clinical Microbiology & Infectious Diseases 38, 1753-1763, 2019 | 60 | 2019 |
Arnaud MarchantUniversité Libre de Bruxellesulb.ac.be의 이메일 확인됨